Amsterdam, Netherlands

Peter Christian Sijmons


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Peter Christian Sijmons: Innovator in Phytase Expression

Introduction

Peter Christian Sijmons is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the expression of phytase in transgenic plants. With a total of three patents to his name, Sijmons has demonstrated a commitment to advancing agricultural science.

Latest Patents

One of Sijmons' latest patents focuses on the expression of phytase in transgenic plants or plant organs. This invention provides methods for producing such plants, utilizing DNA expression constructs for the transformation of plants with a gene encoding phytase. The regulatory sequences included in these constructs are capable of directing the expression of phytase, either constitutively or in a stage and/or tissue-specific manner. The transgenic plants and plant organs developed through this invention can be applied in various industrial processes, such as animal feeds, or the expressed phytase can be extracted and purified for further applications.

Career Highlights

Throughout his career, Sijmons has worked with several prominent companies, including Mogen International and Gist-Brocades N.V. His work in these organizations has allowed him to contribute to significant advancements in biotechnology and plant sciences.

Collaborations

Sijmons has collaborated with notable colleagues such as Albert J Van Ooijen and Andreas Hoekema. These partnerships have further enriched his research and development efforts in the field.

Conclusion

Peter Christian Sijmons is a distinguished inventor whose work in phytase expression has the potential to impact various industries. His innovative approaches and collaborations highlight his dedication to advancing agricultural biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…